These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26503845)

  • 1. MECHANISMS IN ENDOCRINOLOGY: MicroRNA in diagnostics and therapy of thyroid cancer.
    Wójcicka A; Kolanowska M; Jażdżewski K
    Eur J Endocrinol; 2016 Mar; 174(3):R89-98. PubMed ID: 26503845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas.
    Pallante P; Visone R; Croce CM; Fusco A
    Endocr Relat Cancer; 2010 Mar; 17(1):F91-104. PubMed ID: 19942715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications.
    Menon MP; Khan A
    J Clin Pathol; 2009 Nov; 62(11):978-85. PubMed ID: 19625289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two miRNA classifier differentiates follicular thyroid carcinomas from follicular thyroid adenomas.
    Stokowy T; Wojtaś B; Krajewska J; Stobiecka E; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Jarząb B; Krohn K; Paschke R; Eszlinger M
    Mol Cell Endocrinol; 2015 Jan; 399():43-9. PubMed ID: 25258301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of BRAF V600E mutation in the differential diagnosis of follicular and papillary tumors of the thyroid and for the optimization of thearpy].
    Semënov DIu; Boriskova ME; Zaraĭskiĭ MI; Saburova IIu; Pankova PA; Farafonova UV; Bykov MA
    Vopr Onkol; 2012; 58(5):649-52. PubMed ID: 23600282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-expression profiling in differentiated thyroid cancer--a viable strategy for the practice of genomic medicine?
    Weber F; Eng C
    Future Oncol; 2005 Aug; 1(4):497-510. PubMed ID: 16556026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Well differentiated follicular thyroid neoplasia: impact of molecular and technological advances on detection, monitoring and treatment.
    Gianoukakis AG; Giannelli SM; Salameh WA; McPhaul LW
    Mol Cell Endocrinol; 2011 Jan; 332(1-2):9-20. PubMed ID: 21094678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular cell-derived thyroid cancer in children.
    Leboulleux S; Baudin E; Hartl DW; Travagli JP; Schlumberger M
    Horm Res; 2005; 63(3):145-51. PubMed ID: 15802922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of differentiated thyroid cancer of the follicular epithelium.
    Pacini F
    Ann Med; 2012 Nov; 44(7):651-5. PubMed ID: 21668295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Let-7a down-regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) gene.
    Colamaio M; Calì G; Sarnataro D; Borbone E; Pallante P; Decaussin-Petrucci M; Nitsch L; Croce CM; Battista S; Fusco A
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2168-78. PubMed ID: 22965940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiated thyroid cancers of follicular cell origin.
    Yip L; Carty SE
    Cancer Treat Res; 2010; 153():35-56. PubMed ID: 19957218
    [No Abstract]   [Full Text] [Related]  

  • 12. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma.
    Rossing M; Borup R; Henao R; Winther O; Vikesaa J; Niazi O; Godballe C; Krogdahl A; Glud M; Hjort-Sørensen C; Kiss K; Bennedbæk FN; Nielsen FC
    J Mol Endocrinol; 2012 Feb; 48(1):11-23. PubMed ID: 22049245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
    Bryson PC; Shores CG; Hart C; Thorne L; Patel MR; Richey L; Farag A; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):581-6. PubMed ID: 18559722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy.
    Riesco-Eizaguirre G; Santisteban P
    Endocr Relat Cancer; 2007 Dec; 14(4):957-77. PubMed ID: 18045949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Update on differenciated thyroid carcinoma].
    Karayan L; Hadjadj S; Larsen CJ; Maréchaud R; Kraimps JL
    Bull Cancer; 2002 Jan; 89(1):113-23. PubMed ID: 11847033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling.
    Zhao J; Leonard C; Gemsenjäger E; Heitz PU; Moch H; Odermatt B
    Oncol Rep; 2008 Feb; 19(2):329-37. PubMed ID: 18202778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TERT Promoter Mutated Follicular Thyroid Carcinomas Exhibit a Distinct microRNA Expressional Profile with Potential Implications for Tumor Progression.
    Paulsson JO; Zedenius J; Juhlin CC
    Endocr Pathol; 2021 Dec; 32(4):513-516. PubMed ID: 34676499
    [No Abstract]   [Full Text] [Related]  

  • 18. [Approach to thyroid incidentaloma and follicular adenoma].
    Tajiri J
    Nihon Rinsho; 2007 Nov; 65(11):2099-105. PubMed ID: 18018577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis, treatment, and outcome of follicular thyroid carcinoma.
    Collin JV
    Cancer; 1994 Aug; 74(3):985-6. PubMed ID: 8039129
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of follicular tumors of the thyroid.
    Wang TS; Roman SA; Sosa JA
    Minerva Chir; 2007 Oct; 62(5):373-82. PubMed ID: 17947948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.